Adipose stems cells used for bladder smooth muscle

Article

Autologous adipose stem cells lend themselves well to theengineering of bladder smooth muscle and may eventually make theuse of gastrointestinal tissue for this purpose obsolete, say theauthors of an animal study from UCLA. The group reports that it hasshown, for the first time, that adipose stem cells can bedifferentiated into functional smooth muscle.

Autologous adipose stem cells lend themselves well to the engineering of bladder smooth muscle and may eventually make the use of gastrointestinal tissue for this purpose obsolete, say the authors of an animal study from UCLA. The group reports that it has shown, for the first time, that adipose stem cells can be differentiated into functional smooth muscle.

"The advantage of using stem cells is that they are pluripotent and capable of forming multiple tissue types, including smooth muscle," said Larissa V. Rodríguez, MD. "The particular advantage of using adipose stem cells is that it makes this an autologous model, and therefore there is no need for immunosuppression."

The researchers processed adipose stem cells (ASCs) from human lipospirate. ASCs were then differentiated into smooth muscle phenotype (SM-ASCs) using smooth muscle-inductive cultured media.

A group of 45 female nude rats underwent laparotomy, removal of bladder dome, and repair using partial cystectomy, unseeded scaffold, or scaffold seeded with SM-ASCs. Follow-up over 12 weeks showed that tissue-engineered rats maintained smooth muscle mRNA and protein in vitro, along with bladder capacity and compliance at all follow-up points in vivo. Animals given unseeded scaffold, meanwhile, lost capacity over time and experienced poor compliance. Lower bladder volume was also seen in the cystectomy group.

Related Videos
Kevin M. Wymer, MD
Video 7 - "Multidisciplinary Collaboration and Expert Insights in the Management of Advanced Prostate Cancer"
Video 6 - "Emerging AR Targeting Agents and CDK4/6 Inhibitors in Metastatic Prostate Cancer and Potential Impact on the Treatment Landscape"
Video 5 - "Targeting the Androgen Receptor Pathway and Overcoming Treatment Resistance in Advanced Prostate Cancer"
Video 4 - "Androgen Receptor Signaling and Its Role in Driving Prostate Cancer Metastasis"
Video 3 - "Treatment Selection in Metastatic and Castration Resistant Prostate Cancer: Optimizing Outcomes and Preserving Patient Quality of Life"
Video 2 - "Predicting Risk and Guiding Care: Biomarkers & Genetic Testing in Prostate Cancer"
Video 1 - "Metastatic Prostate Cancer: Background and Patient Prognosis"
Related Content
© 2024 MJH Life Sciences

All rights reserved.